메뉴 건너뛰기




Volumn 354, Issue , 2016, Pages

Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: Population based cohort study

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; METFORMIN; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT;

EID: 84979075783     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i3625     Document Type: Article
Times cited : (70)

References (35)
  • 2
  • 3
    • 0029658824 scopus 로고    scopus 로고
    • Mechanisms of the glycaemic effects of sulfonylureas
    • Ashcroft FM. Mechanisms of the glycaemic effects of sulfonylureas. Horm Metab Res 1996; 28: 456-63. doi: 10.1055/s-2007-979837.
    • (1996) Horm Metab Res , vol.28 , pp. 456-463
    • Ashcroft, F.M.1
  • 4
    • 0035667081 scopus 로고    scopus 로고
    • Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide
    • Holstein A, Plaschke A, Egberts EH. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 2001; 17: 467-73. doi: 10.1002/dmrr.235.
    • (2001) Diabetes Metab Res Rev , vol.17 , pp. 467-473
    • Holstein, A.1    Plaschke, A.2    Egberts, E.H.3
  • 5
    • 0029949970 scopus 로고    scopus 로고
    • Individual sulfonylureas and serious hypoglycemia in older people
    • Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996; 44: 751-5. doi: 10.1111/j.1532-5415.1996.tb03729.x.
    • (1996) J Am Geriatr Soc , vol.44 , pp. 751-755
    • Shorr, R.I.1    Ray, W.A.2    Daugherty, J.R.3    Griffin, M.R.4
  • 6
    • 0028019713 scopus 로고
    • Glibenclamide vs gliclazide in type 2 diabetes of the elderly
    • Tessier D, Dawson K, Tétrault JP, Bravo G, Meneilly GS. Glibenclamide vs gliclazide in type 2 diabetes of the elderly. Diabet Med 1994; 11: 974-80. doi: 10.1111/j.1464-5491.1994.tb00256.x.
    • (1994) Diabet Med , vol.11 , pp. 974-980
    • Tessier, D.1    Dawson, K.2    Tétrault, J.P.3    Bravo, G.4    Meneilly, G.S.5
  • 8
    • 79958197888 scopus 로고    scopus 로고
    • Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study
    • Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study. Eur Heart J 2011; 32: 1900-8. doi: 10.1093/eurheartj/ehr077.
    • (2011) Eur Heart J , vol.32 , pp. 1900-1908
    • Schramm, T.K.1    Gislason, G.H.2    Vaag, A.3
  • 9
    • 84892465849 scopus 로고    scopus 로고
    • The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: A systematic review and meta-analysis
    • Schopman JE, Simon AC, Hoefnagel SJ, Hoekstra JB, Scholten RJ, Holleman F. The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: A systematic review and meta-analysis. Diabetes Metab Res Rev 2014; 30: 11-22. doi: 10.1002/dmrr.2470.
    • (2014) Diabetes Metab Res Rev , vol.30 , pp. 11-22
    • Schopman, J.E.1    Simon, A.C.2    Hoefnagel, S.J.3    Hoekstra, J.B.4    Scholten, R.J.5    Holleman, F.6
  • 10
    • 0030852089 scopus 로고    scopus 로고
    • Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
    • Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681-6. doi: 10.1001/ archinte.1997.00440360095010.
    • (1997) Arch Intern Med , vol.157 , pp. 1681-1686
    • Shorr, R.I.1    Ray, W.A.2    Daugherty, J.R.3    Griffin, M.R.4
  • 11
    • 0032756168 scopus 로고    scopus 로고
    • Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas
    • Stahl M, Berger W. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas. Diabet Med 1999; 16: 586-90. doi: 10.1046/j.1464-5491.1999.00110.x.
    • (1999) Diabet Med , vol.16 , pp. 586-590
    • Stahl, M.1    Berger, W.2
  • 12
    • 0041666594 scopus 로고    scopus 로고
    • DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use
    • Leese GP, Wang J, Broomhall J, et al. DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use. Diabetes Care 2003; 26: 1176-80. doi: 10.2337/ diacare.26.4.1176.
    • (2003) Diabetes Care , vol.26 , pp. 1176-1180
    • Leese, G.P.1    Wang, J.2    Broomhall, J.3
  • 13
    • 0030758711 scopus 로고    scopus 로고
    • Rates of hypoglycemia in users of sulfonylureas
    • Van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997; 50: 735-41. doi: 10.1016/ S0895-4356(97)00024-3.
    • (1997) J Clin Epidemiol , vol.50 , pp. 735-741
    • Van Staa, T.1    Abenhaim, L.2    Monette, J.3
  • 14
    • 79958080038 scopus 로고    scopus 로고
    • Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: A population-based nested case-control study
    • Weir MA, Gomes T, Mamdani M, et al. Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: A population-based nested case-control study. Nephrol Dial Transplant 2011; 26: 1888-94. doi: 10.1093/ndt/gfq649.
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 1888-1894
    • Weir, M.A.1    Gomes, T.2    Mamdani, M.3
  • 15
    • 77955963898 scopus 로고    scopus 로고
    • Severe sulfonylurea-induced hypoglycemia: A problem of uncritical prescription and deficiencies of diabetes care in geriatric patients
    • Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Severe sulfonylurea-induced hypoglycemia: A problem of uncritical prescription and deficiencies of diabetes care in geriatric patients. Expert Opin Drug Saf 2010; 9: 675-81. doi: 10.1517/14740338.2010.492777.
    • (2010) Expert Opin Drug Saf , vol.9 , pp. 675-681
    • Holstein, A.1    Hammer, C.2    Hahn, M.3    Kulamadayil, N.S.4    Kovacs, P.5
  • 16
    • 77951039382 scopus 로고    scopus 로고
    • Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older
    • Greco D, Pisciotta M, Gambina F, Maggio F. Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older. Exp Clin Endocrinol Diabetes 2010; 118: 215-9. doi: 10.1055/s-0029-1241823.
    • (2010) Exp Clin Endocrinol Diabetes , vol.118 , pp. 215-219
    • Greco, D.1    Pisciotta, M.2    Gambina, F.3    Maggio, F.4
  • 17
    • 84959475663 scopus 로고    scopus 로고
    • Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/ Austria: How big is the problem? Which patients are at risk?
    • Schloot NC, Haupt A, Schutt M, et al. Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/ Austria: How big is the problem? which patients are at risk? Diabetes Metab Res Rev 2016; 32: 316-24. doi: 10.1002/dmrr.2722.
    • (2016) Diabetes Metab Res Rev , vol.32 , pp. 316-324
    • Schloot, N.C.1    Haupt, A.2    Schutt, M.3
  • 18
    • 84939607655 scopus 로고    scopus 로고
    • Data resource profile: Clinical practice research datalink (CPRD
    • Herrett E, Gallagher AM, Bhaskaran K, et al. Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015; 44: 827-36. doi: 10.1093/ije/dyv098.
    • (2015) Int J Epidemiol , vol.44 , pp. 827-836
    • Herrett, E.1    Gallagher, A.M.2    Bhaskaran, K.3
  • 19
    • 72949102852 scopus 로고    scopus 로고
    • Validation and validity of diagnoses in the General Practice Research Database: A systematic review
    • Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: A systematic review. Br J Clin Pharmacol 2010; 69: 4-14. doi: 10.1111/j.1365-2125.2009.03537.x.
    • (2010) Br J Clin Pharmacol , vol.69 , pp. 4-14
    • Herrett, E.1    Thomas, S.L.2    Schoonen, W.M.3    Smeeth, L.4    Hall, A.J.5
  • 20
    • 0028580451 scopus 로고
    • The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions
    • Van Staa T, Abenhaim L. The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 1994; 3: 15-21. doi: 10.1002/pds.2630030106.
    • (1994) Pharmacoepidemiol Drug Saf , vol.3 , pp. 15-21
    • Van Staa, T.1    Abenhaim, L.2
  • 22
    • 84905736258 scopus 로고    scopus 로고
    • Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK-A nested case-control analysis
    • Bruderer SG, Bodmer M, Jick SS, Bader G, Schlienger RG, Meier CR. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK-A nested case-control analysis. Diabetes Obes Metab 2014; 16: 801-11. doi: 10.1111/dom.12282.
    • (2014) Diabetes Obes Metab , vol.16 , pp. 801-811
    • Bruderer, S.G.1    Bodmer, M.2    Jick, S.S.3    Bader, G.4    Schlienger, R.G.5    Meier, C.R.6
  • 23
    • 33845267499 scopus 로고    scopus 로고
    • Beta blockers in the management of chronic kidney disease
    • Bakris GL, Hart P, Ritz E. Beta blockers in the management of chronic kidney disease. Kidney Int 2006; 70: 1905-13. doi: 10.1038/sj.ki.5001835.
    • (2006) Kidney Int , vol.70 , pp. 1905-1913
    • Bakris, G.L.1    Hart, P.2    Ritz, E.3
  • 24
    • 33751003491 scopus 로고    scopus 로고
    • Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73
    • Wright AD, Cull CA, Macleod KM, Holman RR. UKPDS Group. Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. J Diabetes Complications 2006; 20: 395-401. doi: 10.1016/j.jdiacomp.2005.08.010.
    • (2006) J Diabetes Complications , vol.20 , pp. 395-401
    • Wright, A.D.1    Cull, C.A.2    Macleod, K.M.3    Holman, R.R.4    Ukpds, G.5
  • 25
    • 78651514144 scopus 로고    scopus 로고
    • Drug-induced hypoglycaemia: An update
    • Ben Salem C, Fathallah N, Hmouda H, Bouraoui K. Drug-induced hypoglycaemia: An update. Drug Saf 2011; 34: 21-45. doi: 10.2165/11538290-000000000-00000.
    • (2011) Drug Saf , vol.34 , pp. 21-45
    • Ben Salem, C.1    Fathallah, N.2    Hmouda, H.3    Bouraoui, K.4
  • 26
    • 59249083934 scopus 로고    scopus 로고
    • Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis
    • Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: A nested case-control analysis. Diabetes Care 2008; 31: 2086-91. doi: 10.2337/dc08-1171.
    • (2008) Diabetes Care , vol.31 , pp. 2086-2091
    • Bodmer, M.1    Meier, C.2    Krähenbühl, S.3    Jick, S.S.4    Meier, C.R.5
  • 27
    • 0029839173 scopus 로고    scopus 로고
    • Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells
    • Kramer W, Müller G, Geisen K. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells. Horm Metab Res 1996; 28: 464-8. doi: 10.1055/s-2007-979838.
    • (1996) Horm Metab Res , vol.28 , pp. 464-468
    • Kramer, W.1    Müller, G.2    Geisen, K.3
  • 28
    • 0028332660 scopus 로고
    • Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics
    • Müller G, Hartz D, Pünter J, Okonomopulos R, Kramer W. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics. Biochim Biophys Acta 1994; 1191: 267-77. doi: 10.1016/0005-2736(94)90177-5.
    • (1994) Biochim Biophys Acta , vol.1191 , pp. 267-277
    • Müller, G.1    Hartz, D.2    Pünter, J.3    Okonomopulos, R.4    Kramer, W.5
  • 29
    • 0032835309 scopus 로고    scopus 로고
    • Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man
    • Raptis SA, Hatziagelaki E, Dimitriadis G, Draeger KE, Pfeiffer C, Raptis AE. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man. Exp Clin Endocrinol Diabetes 1999; 107: 350-5. doi: 10.1055/s-0029-1212125.
    • (1999) Exp Clin Endocrinol Diabetes , vol.107 , pp. 350-355
    • Raptis, S.A.1    Hatziagelaki, E.2    Dimitriadis, G.3    Draeger, K.E.4    Pfeiffer, C.5    Raptis, A.E.6
  • 30
    • 0029852409 scopus 로고    scopus 로고
    • Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): A double-blind comparison with glibenclamide
    • Draeger KE, Wernicke-Panten K, Lomp HJ, Schüler E, Rosskamp R. Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): A double-blind comparison with glibenclamide. Horm Metab Res 1996; 28: 419-25. doi: 10.1055/s-2007-979830.
    • (1996) Horm Metab Res , vol.28 , pp. 419-425
    • Draeger, K.E.1    Wernicke-Panten, K.2    Lomp, H.J.3    Schüler, E.4    Rosskamp, R.5
  • 31
    • 6944221200 scopus 로고    scopus 로고
    • Gliclazide modified release: Results of a 2-year study in patients with type 2 diabetes
    • Drouin P, Standl E, Diamicron MRSG. Diamicron MR Study Group. Gliclazide modified release: Results of a 2-year study in patients with type 2 diabetes. Diabetes Obes Metab 2004; 6: 414-21. doi: 10.1111/j.1462-8902.2004.00404.x.
    • (2004) Diabetes Obes Metab , vol.6 , pp. 414-421
    • Drouin, P.1    Standl, E.2    Diamicron, M.R.S.G.3
  • 32
    • 79956101975 scopus 로고    scopus 로고
    • 2009 Ramadan Study Group. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: A five-country observational study
    • Aravind SR, Al Tayeb K, Ismail SB, et al. 2009 Ramadan Study Group. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: A five-country observational study. Curr Med Res Opin 2011; 27: 1237-42. doi: 10.1185/03007995.2011.578245.
    • (2011) Curr Med Res Opin , vol.27 , pp. 1237-1242
    • Aravind, S.R.1    Al Tayeb, K.2    Ismail, S.B.3
  • 34
    • 84882932426 scopus 로고    scopus 로고
    • Avoiding hypoglycemia: A key to success for glucoselowering therapy in type 2 diabetes
    • Ahrén B. Avoiding hypoglycemia: A key to success for glucoselowering therapy in type 2 diabetes. Vasc Health Risk Manag 2013; 9: 155-63. doi: 10.2147/VHRM.S33934.
    • (2013) Vasc Health Risk Manag , vol.9 , pp. 155-163
    • Ahrén, B.1
  • 35
    • 84910134162 scopus 로고    scopus 로고
    • Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes
    • Dendy JA, Chockalingam V, Tirumalasetty NN, et al. Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes. Endocr Pract 2014; 20: 1051-6. doi: 10.4158/EP13467.OR.
    • (2014) Endocr Pract , vol.20 , pp. 1051-1056
    • Dendy, J.A.1    Chockalingam, V.2    Tirumalasetty, N.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.